Suivre
Aytug Kara
Titre
Citée par
Citée par
Année
3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals
DR Serrano, A Kara, I Yuste, FC Luciano, B Ongoren, BJ Anaya, G Molina, ...
Pharmaceutics 15 (2), 313, 2023
892023
Understanding direct powder extrusion for fabrication of 3D printed personalised medicines: A case study for nifedipine minitablets
SA Sánchez-Guirales, N Jurado, A Kara, A Lalatsa, DR Serrano
Pharmaceutics 13 (10), 1583, 2021
362021
Development of advanced 3D-printed solid dosage pediatric formulations for HIV treatment
AM Malebari, A Kara, AN Khayyat, KA Mohammad, DR Serrano
Pharmaceuticals 15 (4), 435, 2022
332022
Engineering 3D printed microfluidic chips for the fabrication of nanomedicines
A Kara, A Vassiliadou, B Ongoren, W Keeble, R Hing, A Lalatsa, ...
Pharmaceutics 13 (12), 2134, 2021
332021
Engineering of 3D printed personalized polypills for the treatment of the metabolic syndrome
BJ Anaya, JR Cerda, RM D’Atri, I Yuste, FC Luciano, A Kara, HK Ruiz, ...
International Journal of Pharmaceutics 642, 123194, 2023
272023
Artificial intelligence (AI) applications in drug discovery and drug delivery: Revolutionizing personalized medicine
DR Serrano, FC Luciano, BJ Anaya, B Ongoren, A Kara, G Molina, ...
Pharmaceutics 16 (10), 1328, 2024
122024
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics 15
DR Serrano, A Kara, I Yuste, FC Luciano, B Ongoren, BJ Anaya, G Molina, ...
62023
Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability
B Ongoren, A Kara, L Casettari, M Tiboni, A Lalatsa, A Sanz-Perez, ...
International Journal of Pharmaceutics 663, 124536, 2024
42024
3D Printing Technologies for Personalized Drug Delivery
A Kara, JR Cerda, I Yuste, FC Luciano, BJ Anaya, DR Serrano
Emerging Drug Delivery and Biomedical Engineering Technologies, 31-47, 2023
42023
In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration
M Rodríguez-Torrado, A Kara, S Torrado, A Romero, A Juberías, ...
Pharmaceutics 14 (12), 2615, 2022
42022
Continuous manufacturing of cocrystals using 3d-printed microfluidic chips coupled with spray coating
A Kara, D Kumar, AM Healy, A Lalatsa, DR Serrano
Pharmaceuticals 16 (8), 1064, 2023
32023
3D printing in personalized medicine
B Ongoren, I Yuste, BJ Anaya, FC Luciano, SA Sánchez-Guirales, A Kara, ...
Fundamentals and future trends of 3D printing in drug delivery, 101-126, 2025
2025
Active Targeting of Nanomedicines
DR Serrano Lopez, A Kara, BI Ramirez, IO Ramirez, B Őngoren, A Lalatsa
Fundamentals of Pharmaceutical Nanoscience, 337-385, 2024
2024
Active targeting of nanomedicines
DR Serrano, A Kara, BI Ramirez, IO Ramirez, B Ongoren, A Lalatsa
Fundamentals of Pharmaceutical Nanoscience, 337-385, 2024
2024
Unraveling the Impact of the Oil Phase on the Physicochemical Stability and Skin Permeability of Melatonin Gel Formulations
JJ Torrado, BJ Anaya, A Kara, B Ongoren, S Esteban-Ruiz, A Laguna, ...
Gels 10 (9), 595, 2024
2024
Aprender a emprender entre los estudiantes de posgrado en disciplinas STEM
DR Serrano López, BJ Anaya Meza, L Bautista Chávez, ...
2024
Continuous microfluidic manufacture of cocrystals using 3D printed chips coupled with spray coating
A Kara, D Kumar, AM Healy, K Lalatsa, DR Serrano
Pharmaceuticals 16 (8), 2023
2023
Aprender a emprender entre los estudiantes universitarios de posgrado
DR Serrano López, BJ Anaya Meza, L Bautista Chávez, MA Dea Ayuela, ...
2023
Hydrophobic ion pair for the oral delivery of leucine-enkephalin
B Ongoren, A Kara, DR Serrano, A Lalatsa
AAPS PharmSci360 Annual Meeting 2022, 2022
2022
Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines. Pharmaceutics 2021, 13, 2134
A Kara, A Vassiliadou, B Ongoren, W Keeble, R Hing, A Lalatsa, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20